October 2023 | ATMA Journey Centers

October 24, 2023October 23, 2023ATMA Media Releases, ATMA News

ATMA Welcomes Dr. Scott Shannon, MAPS MDMA Phase 3 Principal Investigator, to Expand Its’ Clinical Training Expertise in MDMA-Assisted Therapy

CALGARY, October 24, 2023 – ATMA Journey Centers Inc. (“ATMA”), a Canadian company with a primary focus on advancing psychedelic-assisted therapy, is […]

October 20, 2023October 19, 2023ATMA Media Releases, ATMA News

ATMA and Cena Life Announce Joint-Venture to Support Psychedelic-Assisted Therapy in Canada

ATMA and Cena Life Announce Joint-Venture to Support Psychedelic-Assisted Therapy in Canada CALGARY, October 20, 2023 – ATMA Journey Centers Inc. (“ATMA”), […]

October 3, 2023October 3, 2023Blog

Psychedelic-Assisted Therapy: Ethics, and Respect Considerations

Psychedelic-Assisted Therapy: Ethics, and Respect Considerations The renewed interest in psychedelic-assisted therapy signals a major change in mental healthcare. Substances such as […]